Researchers sought to compare the efficacy of a standard version of an internet-delivered CBT-I program, a culturally tailored version, and a sleep education control at improving insomnia symptoms.
In a retrospective, systematic review, researchers assessed the effectiveness and safety profile of Wuling for the treatment of insomnia.
Richard K. Bogan, MD, discusses the importance of lowering sodium intake and improving heart health for patients with narcolepsy.
Daridorexant is a dual orexin receptor antagonist designed to suppress wake drive by blocking the binding of wake-promoting neuropeptides orexin A and orexin B to its receptors.
In a systematic review and meta-analysis, researchers compared and evaluated the effect differences of multiple acupuncture therapies for patients with primary insomnia.
Patients with COVID-19 have experienced increased sleep disturbances, and individuals who have been more affected by the pandemic had increased nightmares, prior studies have shown. This is the first study of the oneiric activity of people with COVID-19 and the first comparing their oneiric activity with those of individuals who have not had COVID-19.
Researchers sought to identify the trajectories of insomnia in the 12 months following incidence of traumatic brain injury.
Depressive symptoms and sleep disorders, including insomnia, hypersomnia, and disrupted breathing, are considered heart disease risk factors. Other studies have linked sleep disorders and depression. This study analyzes heart disease risk in people with both sleep disorders and depression.
Approximately 5% to 10% of shift workers, including many health care professionals, suffer from shift work disorder, a circadian sleep-wake cycle disorder defined by poor quality sleep.
